title: Angiotensin II potentiates adrenergic and muscarinic modulation of guinea pig intracardiac neurons.
abstract: The intrinsic cardiac plexus represents a major peripheral integration site for neuronal, hormonal, and locally produced neuromodulators controlling efferent neuronal output to the heart. This study examined the interdependence of norepinephrine, muscarinic agonists, and ANG II, to modulate intrinsic cardiac neuronal activity. Intracellular voltage recordings from whole-mount preparations of the guinea pig cardiac plexus were used to determine changes in active and passive electrical properties of individual intrinsic cardiac neurons. Application of either adrenergic or muscarinic agonists induced changes in neuronal resting membrane potentials, decreased afterhyperpolarization duration of single action potentials, and increased neuronal excitability. Adrenergic responses were inhibited by removal of extracellular calcium ions, while muscarinic responses were inhibited by application of TEA. The adrenergic responses were heterogeneous, responding to a variety of receptor-specific agonists (phenylephrine, clonidine, dobutamine, and terbutaline), although α-receptor agonists produced the most frequent responses. Application of ANG II alone produced a significant increase in excitability, while application of ANG II in combination with either adrenergic or muscarinic agonists produced a much larger potentiation of excitability. The ANG II-induced modulation of firing was blocked by the angiotensin type 2 (AT(2)) receptor inhibitor PD 123319 and was mimicked by the AT(2) receptor agonist CGP-42112A. AT(1) receptor blockade with telmasartin did not alter neuronal responses to ANG II. These data demonstrate that ANG II potentiates both muscarinically and adrenergically mediated activation of intrinsic cardiac neurons, doing so primarily via AT(2) receptor-dependent mechanisms. These neurohumoral interactions may be fundamental to regulation of neuronal excitability within the intrinsic cardiac nervous system.
authors.affiliation: Department of Biology, Ithaca College, Ithaca, New York 14850, USA.
authors.forename: Allison E
authors.initials: AE
authors.lastname: Girasole
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Palmer
authors.forename: Samantha L
authors.initials: SL
authors.lastname: Corrado
authors.forename: E
authors.initials: E
authors.lastname: Marie Southerland
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Ardell
authors.forename: Jean C
authors.initials: JC
authors.lastname: Hardwick
mesh_terms: D000322:Adrenergic Agonists / Q000494:pharmacology*; D000804:Angiotensin II / Q000378:metabolism; D057911:Angiotensin Receptor Antagonists / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D004558:Electric Stimulation; D006168:Guinea Pigs; D006321:Heart / Q000294:innervation*; D066298:In Vitro Techniques; D008297:Male; D008564:Membrane Potentials; D018721:Muscarinic Agonists / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D026902:Potassium Channel Blockers / Q000494:pharmacology; D044140:Receptor, Angiotensin, Type 1 / Q000187:drug effects / Q000378:metabolism; D044139:Receptor, Angiotensin, Type 2 / Q000187:drug effects / Q000378:metabolism; D011941:Receptors, Adrenergic / Q000187:drug effects* / Q000378:metabolism; D011976:Receptors, Muscarinic / Q000187:drug effects* / Q000378:metabolism; D013997:Time Factors
chemical_list: D000322:Adrenergic Agonists; D057911:Angiotensin Receptor Antagonists; D018721:Muscarinic Agonists; D026902:Potassium Channel Blockers; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D011941:Receptors, Adrenergic; D011976:Receptors, Muscarinic; D000804:Angiotensin II; D011188:Potassium; D002118:Calcium